Modulation of striatal projection systems by dopamine, Annu Rev Neurosci, vol.34, pp.441-466, 2011. ,
Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry, Progress in Neurobiology, vol.151, pp.57-100, 2017. ,
?FosB: a transcriptional regulator of stress and antidepressant responses, European Journal of Pharmacology, vol.753, pp.66-72, 2015. ,
Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's Disease, Neurobiology of Disease, vol.6, issue.6, pp.461-474, 1999. ,
Time course of striatal ?FosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment, European Journal of Neuroscience, vol.17, issue.3, pp.661-666, 2003. ,
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease, Pharmacological Reviews, vol.65, issue.1, pp.171-222, 2013. ,
A Novel G-Protein-Coupled Receptor Gene Expressed in Striatum, Genomics, vol.69, issue.3, pp.314-321, 2000. ,
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?, Molecular and Cellular Neuroscience, vol.42, issue.4, pp.438-447, 2009. ,
Lack of GPR88 enhances medium spiny neuron activity and alters motorand cue-dependent behaviors, Nat Neurosci, vol.15, issue.11, pp.1547-1555, 2012. ,
Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents, European Journal of Neuroscience, vol.30, issue.3, pp.397-414, 2009. ,
Distribution and Regulation of the G Protein-Coupled Receptor Gpr88 in the Striatum:Relevance to Parkinson's Disease. In: Dushanova J, ed. Mechanisms in Parkinson's Disease -Models and Treatments, pp.393-406, 2012. ,
Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats, Mol Psychiatry, vol.20, issue.8, pp.951-958, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02361884
Functional roles of neurotransmitters and neuromodulators in the dorsal striatum, Learning & Memory, vol.20, issue.1, pp.21-28, 2013. ,
Pharmacological evidence for feedback regulation of dopamine metabolism in solid fetal substantia nigra transplants, J Pharmacol Exp Ther, vol.253, issue.3, pp.1259-1264, 1990. ,
The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain, Nat Biotechnol, vol.19, issue.5, pp.446-450, 2001. ,
Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells, Diabetologia, vol.48, issue.4, pp.709-719, 2005. ,
Behavioral and Anatomical Effects of Long-Term l-Dihydroxyphenylalanine (L-DOPA) Administration in Rats with Unilateral Lesions of the Nigrostriatal System, Experimental Neurology, vol.177, issue.1, pp.252-264, 2002. ,
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA, Eur J Neurosci, vol.10, issue.8, pp.2694-2706, 1998. ,
Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice, Curr Protoc Neurosci, vol.9, p.25, 2007. ,
Chapter II The basal ganglia, Handbook of Chemical Neuroanatomy, pp.371-468, 1996. ,
The unilateral 6-hydroxydopamine lesion model in behavioral brain research, Progress in Neurobiology, vol.50, issue.2-3, pp.275-331, 1996. ,
L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice, J Neurochem, vol.108, issue.3, pp.621-633, 2009. ,
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice, Biol Psychiatry, vol.59, issue.1, pp.64-74, 2006. ,
Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms, Mov. Disord, vol.29, pp.195-202, 2014. ,
Apathy and impulse control disorders: Yin & yang of dopamine dependent behaviors, J. Parkinsons. Dis, vol.5, pp.625-636, 2015. ,
Non-motor features of Parkinson disease, Nat. Rev. Neurosci, vol.18, pp.435-450, 2017. ,
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment, Lancet. Neurol, vol.14, pp.518-549, 2015. ,
, Predictors of dementia in Parkinson disease: A prospective cohort study, vol.83, pp.1253-1260, 2014.
Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: A magnetic resonance imaging shape analysis, Mov. Disord, vol.29, pp.897-903, 2014. ,
The psychosis spectrum in Parkinson disease, Nat. Rev. Neurol, vol.13, pp.81-95, 2017. ,
Prevalence and Characteristics of Dementia in Parkinson Disease, Arch. Neurol, vol.60, p.387, 2003. ,
,
Incidence of and risk factors for cognitive impairment in an early parkinson disease clinical trial cohort, Neurology, vol.73, pp.1469-1477, 2009. ,
Apathy in untreated early-stage Parkinson disease: Relationship with other non-motor symptoms, Mov. Disord, vol.29, pp.1796-1801, 2014. ,
, Trajectories of prediagnostic functioning in Parkinson ' s disease, pp.1-13, 2016.
The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, vol.80, pp.928-930, 2009. ,
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms, Lancet Neurol, vol.8, pp.1128-1139, 2009. ,
Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase, Mov. Disord, vol.31, pp.45-52, 2016. ,
Non-motor symptoms of Parkinson's disease: diagnosis and management, Lancet Neurol, vol.5, pp.235-245, 2006. ,
Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?, Neurosci. Biobehav. Rev, vol.38, pp.60-71, 2014. ,
Cognitive impairment in patients with Parkinson's disease: Diagnosis, biomarkers, and treatment, Lancet Neurol, vol.11, pp.697-707, 2012. ,
Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: A new susceptibility locus on chromosome 1p22-p21?, Am. J. Med. Genet. Part B Neuropsychiatr. Genet, vol.153, pp.1200-1208, 2010. ,
Association study in three different populations between the GPR88 gene and major psychoses, Mol. Genet. genomic Med, vol.2, pp.152-161, 2014. ,
Deleterious mutation in GPR88 is associated with chorea, speech delay, and learning disabilities, Neurol. Genet, vol.2, pp.64-64, 2016. ,
Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine, Mol. Psychiatry, vol.12, pp.167-189, 2007. ,
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?, Mol. Cell. Neurosci, vol.42, pp.438-447, 2009. ,
Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents, Eur. J. Neurosci, vol.30, pp.397-414, 2009. ,
A Novel G-Protein-Coupled Receptor Gene Expressed in Striatum, Online, vol.321, pp.314-321, 2000. ,
, Synthesis, Pharmacological Characterization, and Structure-Activity Relationship Studies of Small Molecular Agonists for the Orphan GPR88 Receptor, vol.5, pp.576-587, 2014.
Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist, Biol. Psychiatry, vol.79, pp.917-927, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01594891
GPR88 is a critical regulator of feeding and body composition in mice, Sci. Rep, vol.7, 2017. ,
Lack of GPR88 enhances medium spiny neuron activity and alters motor-and cue-dependent behaviors, Nat. Neurosci, vol.15, pp.1547-55, 2012. ,
Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist, Biol. Psychiatry, pp.1-11, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01594891
Remodeling of Sensorimotor Brain Connectivity in Gpr88 deficient mice, Brain Connect, vol.7, pp.526-540, 2017. ,
Striatal GPR88 Modulates Foraging Efficiency, J. Neurosci, vol.37, pp.7939-7947, 2017. ,
Lack of anticipatory behavior in Gpr88 knockout mice revealed by automatized home cage phenotyping, Brain Behav, p.12473, 2018. ,
Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats, Mol. Psychiatry, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02361884
,
Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks, Biol. Psychiatry, 2018. ,
Clinical and [18F] dopa PET findings in early Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, vol.59, pp.597-600, 1995. ,
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET, J. Neurol. Neurosurg. Psychiatry, vol.64, pp.314-319, 1998. ,
Differentiating multiple system atrophy from parkinson's disease: Contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging, J. Neurol. Neurosurg. Psychiatry, vol.73, pp.517-523, 2002. ,
Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study, Neuroimage, vol.56, pp.1463-1468, 2011. ,
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease, N. Engl. J. Med, vol.318, pp.876-880, 1988. ,
Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats, Mol. Psychiatry, vol.20, pp.951-958, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02361884
Presynaptic dopaminergic terminal imaging & non-motor symptoms assessment of Parkinson's disease: Evidence for dopaminergic basis?, Parkinsons. Dis, vol.3, pp.1-19, 2017. ,
A flexible statistical power analysis program for the social, behavioral, and biomedical sciences, Behav. Res. Methods, vol.39, pp.175-191, 2007. ,
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates, J. Neurosci. Methods, vol.3, pp.129-149, 1980. ,
Habituation and prepulse inhibition of acoustic startle in rodents, J. Vis. Exp, pp.1-10, 2011. ,
Using the rat forced swim test to assess antidepressant-like activity in rodents, Nat. Protoc, vol.7, pp.1009-1014, 2012. ,
Distinct patterns of ?FosB induction in brain by drugs of abuse, Synapse, vol.62, pp.358-369, 2008. ,
Immunofluorescence in brain sections: simultaneous detection of presynaptic and postsynaptic proteins in identified neurons, Nat. Protoc, vol.1, pp.1887-97, 2006. ,
ImageJ2: ImageJ for the next generation of scientific image data, BMC Bioinformatics, vol.18, pp.1-26, 2017. ,
An open source platform for biological image analysis, Nat. Methods, vol.9, pp.676-682, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02616466
Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease, Mol Psychiatry, vol.19, pp.358-367, 2014. ,
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease, N. Engl. J. Med, vol.318, pp.876-880, 1988. ,
SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit, Psychopharmacology (Berl), vol.181, pp.134-144, 2005. ,
Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress, Neuropharmacology, vol.99, pp.28-37, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01542315
Rearing on Hind Legs, Environmental Novelty, and the Hippocampal Formation, Rev. Neurosci, vol.17, pp.111-133, 2006. ,
The translational study of apathy-an ecological approach, Front. Behav. Neurosci, vol.9, p.241, 2015. ,
, Differential impact of behavioral, social, and emotional apathy on Parkinson's disease, pp.1-6, 2018.
Distinct subtypes of apathy revealed by the apathy motivation index, PLoS One, vol.12, pp.1-15, 2017. ,
The spectrum of cognitive disorders in Parkinson's disease: A data-driven approach, Mov. Disord, vol.28, pp.183-189, 2013. ,
The onset of nonmotor symptoms in parkinson's disease (the ONSET PD study), Mov. Disord, vol.30, pp.229-237, 2015. ,
Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex, Psychopharmacology (Berl), vol.113, pp.487-492, 1994. ,
Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease, Life Sci, vol.125, pp.71-78, 2015. ,
Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin, Behav. Brain Res, vol.259, pp.70-77, 2014. ,
Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia, Stress, vol.17, pp.88-96, 2014. ,
Prepulse inhibition is associated with attention, processing speed, and 123I-FP-CIT SPECT in Parkinson's Disease, J. Parkinsons. Dis, vol.4, pp.77-87, 2014. ,
Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior, Exp. Brain Res, vol.123, pp.60-76, 1998. ,
Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats, Neuroscience, vol.89, pp.1183-1187, 1999. ,
, Spatial remapping of corticostriatal connectivity in parkinson's disease, vol.20, pp.1175-1186, 2010.
Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity, Mov. Disord, vol.28, pp.447-454, 2013. ,
Mice lacking GPR88 show motor deficit, improved spatial learning and low anxiety reversed by delta opioid antagonist, Biol. Psychiatry, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01594891
?fosB: A transcriptional regulator of stress and antidepressant responses, Eur. J. Pharmacol, vol.753, pp.66-72, 2015. ,
?fosB: A transcriptional regulator of stress and antidepressant responses, Eur. J. Pharmacol, vol.753, pp.66-72, 2015. ,
Putaminal upregulation of FosB/?FosB-like immunoreactivity in Parkinson's disease patients with Dyskinesia, J. Parkinsons. Dis, vol.1, pp.347-357, 2011. ,
Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment, Brain Res, vol.825, pp.104-114, 1999. ,
D1-receptor-related priming is attenuated by antisense-meditated "knockdown" of fosB expression, Mol. Brain Res, vol.53, pp.69-77, 1998. ,
Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats, Brain Res, vol.771, pp.271-277, 1997. ,
l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function, Neurobiol. Dis, vol.10, pp.165-186, 2002. ,
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery, Brain, vol.130, pp.2898-2914, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00391588
Volume Transmission in the Brain: Beyond the Synapse, J. Neuropsychiatry Clin. Neurosci, vol.26, pp.1-4, 2014. ,
A Role for Mitogen-and Stress-Activated Kinase 1 in L-DOPA Induced Dyskinesia and ?FosB Expression, Biol. Psychiatry, vol.79, pp.362-371, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01541323
The Heterogeneity of Early Parkinson's Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients, PLoS One, vol.8, pp.1-8, 2013. ,
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease, J. Neurol, vol.261, pp.2112-2118, 2014. ,
Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease, J. Neural Transm, vol.114, pp.331-335, 2007. ,
, Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease, vol.138, pp.2964-2973, 2015.
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?, Transl. Psychiatry, vol.6, p.753, 2016. ,
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease, Nat. Rev. Neurosci, vol.11, pp.760-772, 2010. ,
Addiction: failure of control over maladaptive incentive habits, Curr. Opin. Neurobiol, pp.564-572, 2013. ,
Striatal circuits, habits, and implications for obsessive-compulsive disorder, Curr. Opin. Neurobiol, vol.30, pp.59-65, 2015. ,
, Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease, vol.12, pp.1-19, 2017.
,
Long-term safety and tolerability of ProSavin , a lentiviral vector-based gene therapy for Parkinson ' s disease : a dose escalation , open-label, vol.383, p.61939, 2014. ,
Long-term follow up of a phase 1/2 study of ProSavin, a lentiviral vector gene therapy for Parkinson's disease, Hum, Gene Ther. Clin. Dev, vol.33, 2018. ,
An essay on the shaking palsy, J Neuropsychiatry Clin, vol.14, pp.223-236, 2002. ,
Lectures on the disease of the nervous system, New Sydenham Soc. XC, Plate V, 1877. ,
Leçons sur les maladies nerveuses, Masson, vol.2, 1899. ,
Contribution a l'etude l'anatomie pathologique du locus Niger de soemmering: avec quelques déductions relatives à la pathogénie des troubles du tonus musculaire et de la maladie de Parkinson, 1919. ,
Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system, Park. Relat. Disord, vol.4, pp.53-57, 1998. ,
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr, Mov. Disord, vol.30, pp.19-36, 2015. ,
, Parkinson's Foundation. at <parkinson.org> 8. Association France Parkinson
The epidemiology of Parkinson's disease: risk factors and prevention, Lancet Neurol, vol.15, pp.1257-1272, 2016. ,
Estimated life expectancy of Parkinson's patients compared with the UK population, J. Neurol. Neurosurg. Psychiatry, vol.78, pp.1304-1309, 2007. ,
Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: A 9-year follow-up, Mov. Disord, vol.18, pp.1312-1316, 2003. ,
Parkinson's disease, Lancet, vol.386, pp.896-912, 2015. ,
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy, Mov. Disord, vol.32, pp.1264-1310, 2017. ,
Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms, Mov. Disord, vol.29, pp.195-202, 2014. ,
The onset of nonmotor symptoms in parkinson's disease (the ONSET PD study), Mov. Disord, vol.30, pp.229-237, 2015. ,
Non-motor features of Parkinson disease, Nat. Rev. Neurosci, vol.18, pp.435-450, 2017. ,
Non-motor symptoms of Parkinson's disease: diagnosis and management, Lancet Neurol, vol.5, pp.235-245, 2006. ,
Apathy in untreated early-stage Parkinson disease: Relationship with other non-motor symptoms, Mov. Disord, vol.29, pp.1796-1801, 2014. ,
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment, Lancet. Neurol, vol.14, pp.518-549, 2015. ,
Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits, Cereb. Cortex, vol.16, pp.916-928, 2006. ,
Emotional, and Auto-Activation Dimensions of Apathy in Parkinson's Disease, Front. Behav. Neurosci, vol.11, 2017. ,
Apathy may herald cognitive decline and dementia in Parkinson's disease, Mov. Disord, vol.24, pp.2391-2397, 2009. ,
Apathy and Anhedonia Rating Scales in Parkinson's Disease: Critique and Recommendations, Mov. Disord, vol.23, 2004. ,
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease, J. Neurol. Sci, vol.248, pp.266-270, 2006. ,
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study, Mov Disord, vol.15, pp.669-677, 2000. ,
The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, vol.80, pp.928-930, 2009. ,
Trajectories of prediagnostic functioning in Parkinson ' s disease, Brain, vol.1, p.13, 2016. ,
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms, Lancet Neurol, vol.8, pp.1128-1139, 2009. ,
The spectrum of cognitive disorders in Parkinson's disease: A data-driven approach, Mov. Disord, vol.28, pp.183-189, 2013. ,
Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients, J. Neurol, vol.251, pp.1383-1392, 2004. ,
Deficits in decoding emotional facial expressions in Parkinson's disease, Neuropsychologia, vol.42, pp.239-250, 2004. ,
Prepulse inhibition is associated with attention, processing speed, and 123I-FP-CIT SPECT in Parkinson's Disease, J. Parkinsons. Dis, vol.4, pp.77-87, 2014. ,
Memory and executive function in sporadic and familial Parkinson's disease, Brain, vol.124, pp.389-98, 2001. ,
Cognitive impairment in patients with Parkinson's disease: Diagnosis, biomarkers, and treatment, Lancet Neurol, vol.11, pp.697-707, 2012. ,
The psychosis spectrum in Parkinson disease, Nat. Rev. Neurol, vol.13, pp.81-95, 2017. ,
Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase, Mov. Disord, vol.31, pp.45-52, 2016. ,
Fatigue in Parkinson's disease: A review, Mov. Disord, vol.22, pp.297-308, 2007. ,
Pain in Parkinson's disease: Prevalence and characteristics, Pain, vol.141, pp.173-177, 2009. ,
Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease, Auton. Neurosci, vol.92, pp.76-85, 2001. ,
Sydney Multicenter Study of Parkinson's disease: Non-L-dopa-responsive problems dominate at 15 years, Mov. Disord, vol.20, pp.190-199, 2005. ,
Precision medicine for disease modification in Parkinson disease, Nat. Rev. Neurol, vol.13, pp.119-126, 2017. ,
The Nonmotor Features of Parkinson's Disease, Mov. Disord, vol.31, 2015. ,
The Heterogeneity of Early Parkinson's Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients, PLoS One, vol.8, pp.1-8, 2013. ,
Non motor subtypes and Parkinson's disease, Park. Relat. Disord, vol.22, pp.41-46, 2016. ,
The association between motor subtypes and psychopathology in Parkinson's disease, Park. Relat. Disord, vol.15, pp.379-382, 2009. ,
Clinical heterogeneity in patients with earlystage Parkinson's disease: a cluster analysis, J. Zhejiang Univ. Sci. B, vol.12, pp.694-703, 2011. ,
Course in Parkinson's Disease Subtypes: A 39-year clinicopathological study, Neurology, vol.73, pp.206-212, 2009. ,
Parkinson's disease subtypes: Lost in translation?, J. Neurol. Neurosurg. Psychiatry, vol.84, pp.409-415, 2013. ,
Evaluating the contribution of genetics and familial shared environment to common disease using the UK Biobank, Nat. Genet, vol.48, pp.980-983, 2016. ,
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era, Trends Genet, vol.31, pp.140-149, 2015. ,
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease, Mov. Disord, 2018. ,
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease, Hum. Mol. Genet, vol.21, pp.4996-5009, 2012. ,
An updated review of Parkinson's disease genetics and clinicopathological correlations, Acta Neurol. Scand, vol.135, pp.273-284, 2017. ,
Convergence of mirna expression profiling, ?-synuclein interacton and GWAS in Parkinson's disease, PLoS One, vol.6, 2011. ,
Clinical subtypes and genetic heterogeneity: Of lumping and splitting in Parkinson disease, Curr. Opin. Neurol, vol.29, pp.727-734, 2016. ,
Cognitive deficits in animal models of basal ganglia disorders, Brain Res. Bull, vol.92, pp.29-40, 2013. ,
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease, Neuron, vol.90, pp.675-691, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01348875
The two-century journey of Parkinson disease research, Nat. Rev. Neurosci, vol.18, pp.251-259, 2017. ,
Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, vol.24, pp.197-211, 2003. ,
Neuroinflammation in Parkinson's disease, Park. Relat. Disord, 2012. ,
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest hostto-graft disease propagation, Nat. Med, vol.14, pp.501-503, 2008. ,
Pathological ?-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science (80-. ), vol.353, 2016. ,
Does Parkinson's disease start in the gut?, Acta Neuropathol, vol.135, 2018. ,
Selective neuronal vulnerability in Parkinson disease, Nat. Rev. Neurosci, vol.18, pp.101-113, 2017. ,
Collateral projections from the substantia nigra to the cingulate cortex and striatum in the rat, Brain Res, vol.380, pp.331-335, 1986. ,
Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, 2008. ,
Imaging biomarkers in Parkinson's disease, Prog. Neurobiol, vol.95, pp.614-628, 2011. ,
Clinical and [18F] dopa PET findings in early Parkinson's disease, J. Neurol. Neurosurg. Psychiatry, vol.59, pp.597-600, 1995. ,
Differentiating multiple system atrophy from parkinson's disease: Contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging, J. Neurol. Neurosurg. Psychiatry, vol.73, pp.517-523, 2002. ,
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study, Mov. Disord, vol.21, pp.958-963, 2006. ,
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study, Brain, vol.122, pp.1637-1650, 1999. ,
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease, Neurology, vol.54, pp.1482-1487, 2000. ,
Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex, Brain, vol.124, pp.1125-1130, 2001. ,
Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging, Park. Relat. Disord, vol.15, pp.26-30, 2009. ,
imaging prodromal Parkinson disease; the pasrkinsdon associated risk syndrome study, Neurology, vol.83, pp.1739-1746, 2014. ,
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET, J. Neurol. Neurosurg. Psychiatry, vol.64, pp.314-319, 1998. ,
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease, N. Engl. J. Med, vol.318, pp.876-880, 1988. ,
The vulnerable ventral tegmental area in Parkinson's disease, Basal Ganglia, vol.5, pp.51-55, 2015. ,
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease, Brain, vol.136, pp.2419-2431, 2013. ,
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease, Brain Res, vol.275, pp.321-328, 1983. ,
Serotonin in Parkinson's disease, Behav. Brain Res, vol.277, pp.136-145, 2015. ,
Preserved serotonin transporter binding in de novo Parkinson's disease: Negative correlation with the dopamine transporter, J. Neurol, vol.258, pp.19-26, 2011. ,
Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study, Neuroimage, vol.56, pp.1463-1468, 2011. ,
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease, Brain, vol.138, pp.2964-2973, 2015. ,
Brain serotonin transporter binding in non-depressed patients with Parkinson's disease, Eur. J. Neurol, vol.14, pp.523-528, 2007. ,
Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system, Brain, vol.128, pp.1314-1322, 2005. ,
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease, Brain, vol.131, pp.120-131, 2008. ,
Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease, BMC Neurol, vol.11, 2011. ,
Disease-specific patterns of locus coeruleus cell loss, Ann. Neurol, vol.32, pp.667-676, 1992. ,
A Major External Source of Cholinergic Innervation of the Striatum and Nucleus Accumbens Originates in the Brainstem, J. Neurosci, vol.34, pp.4509-4518, 2014. ,
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET, Neurology, vol.73, 2009. ,
The cholinergic system and Parkinson disease, Behav. Brain Res, vol.221, pp.564-573, 2011. ,
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion, Nat. Neurosci, vol.9, pp.832-842, 2006. ,
The basal nucleus of Meynert in idiopathic Parkinson's disease, Acta Neurol. Scand, vol.70, pp.20-28, 1984. ,
The pedunculopontine nucleus in Parkinson's disease, Ann.Neurol, vol.26, pp.41-46, 1989. ,
Microglial activation and dopamine terminal loss in early Parkinson's disease, Ann. Neurol, vol.57, pp.168-175, 2005. ,
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease, Neurobiol. Dis, vol.21, pp.404-412, 2006. ,
Neuroimaging in Parkinson disease: from research setting to clinical practice, Nat. Rev. Neurol, vol.10, pp.708-722, 2014. ,
Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally, Brain, vol.137, pp.1120-1129, 2014. ,
The human nucleus accumbens suffers parkinsonism-related shrinkage: A novel finding, Surg. Radiol. Anat, vol.33, pp.595-599, 2011. ,
Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: A magnetic resonance imaging shape analysis, Mov. Disord, vol.29, pp.897-903, 2014. ,
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study, Brain, vol.138, pp.2974-2986, 2015. ,
Spatial remapping of cortico-striatal connectivity in parkinson's disease, Cereb. Cortex, vol.20, pp.1175-1186, 2010. ,
Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity, Mov. Disord, vol.28, pp.447-454, 2013. ,
Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease. Hum, Brain Mapp, vol.36, pp.1278-1291, 2015. ,
Cognitive phenotypes in parkinson's disease differ in terms of brain-network organization and connectivity, Hum. Brain Mapp, vol.38, pp.1604-1621, 2017. ,
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease, J. Neurol, vol.261, pp.2112-2118, 2014. ,
Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease, J. Neural Transm, vol.114, pp.331-335, 2007. ,
Parkinson Subtypes Progress Differently in Clinical Course and Imaging Pattern, PLoS One, vol.7, 2012. ,
Noradrenergic deficits in Parkinson's disease imaged with 11 C-MeNER, J. Nucl. Med. jnumed, vol.117, p.190975, 2017. ,
The neuropathologic basis of different clinical subgroups of parkinson's disease, Journal of Neuropathology and Experimental Neurology, vol.50, pp.743-755, 1991. ,
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease, J. Clin. Invest, vol.120, pp.2745-2754, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00795787
Cortical motor reorganization in akinetic patients with Parkinson's disease, Brain, vol.123, pp.394-403, 2000. ,
Functional connectivity alterations in the motor and fronto-parietal network relate to behavioral heterogeneity in Parkinson's disease, Park. Relat. Disord, vol.24, pp.48-55, 2016. ,
Presynaptic dopaminergic terminal imaging & non-motor symptoms assessment of Parkinson's disease: Evidence for dopaminergic basis?, Parkinsons. Dis, vol.3, pp.1-19, 2017. ,
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease, Nat. Rev. Neurosci, vol.11, pp.760-772, 2010. ,
Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease, Proc. Natl. Acad. Sci, vol.114, pp.2735-2740, 2017. ,
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease, Neurobiol. Aging, vol.26, pp.891-898, 2005. ,
Cognitive-nigrostriatal relationships in de novo, drug-na??ve Parkinson's disease patients: A [I-123]FP-CIT SPECT Study, Mov. Disord, vol.25, pp.35-43, 2010. ,
Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of parkinson disease and evidence of interaction effects, JAMA Neurol, vol.72, pp.194-200, 2015. ,
Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease, NeuroImage Clin, vol.14, pp.591-601, 2017. ,
The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease, Front. Behav. Neurosci, vol.6, pp.1-6, 2012. ,
A comprehensive excitatory input map of the striatum reveals novel functional organization, Elife, vol.5, p.19103, 2016. ,
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study, Park. Relat. Disord, vol.20, pp.761-765, 2014. ,
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction, Brain, vol.133, pp.3434-3443, 2010. ,
Putaminal Mosaic Visualized by Tyrosine Hydroxylase Immunohistochemistry in the Human Neostriatum, Front. Neuroanat, vol.10, pp.1-12, 2016. ,
Functional implications of dopamine D1 vs. D2 receptors: A 'prepare and select' model of the striatal direct vs, Neuroscience, vol.282, pp.156-175, 2014. ,
Striatal direct and indirect pathways control decisionmaking behavior, Front. Psychol, vol.5, pp.1-7, 2014. ,
The Nucleus Accumbens: An Interface Between Cognition, Emotion, and Action, Annu. Rev. Psychol, vol.66, pp.25-52, 2015. ,
Presynaptic control of serotonin on striatal dopamine function, Psychopharmacology (Berl), vol.213, pp.213-242, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01178533
Computational studies of the role of serotonin in the basal ganglia, Front. Integr. Neurosci, vol.7, p.41, 2013. ,
Serotonergic action on dorsal striatal function, Parkinsonism Relat. Disord, vol.18, pp.129-131, 2012. ,
Effects of acetylcholine in the striatum: Recent insights and therapeutic implications, Neurology, vol.79, pp.274-281, 2012. ,
Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior, Exp. Brain Res, vol.123, pp.60-76, 1998. ,
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum, Nat. Neurosci, vol.5, pp.446-451, 2002. ,
Cellular basis of the intrastriatal functional shifts that underlie the development of habits: relevance for drug addiction, Curr. Opin. Behav. Sci, vol.13, pp.144-151, 2017. ,
Distinct Roles of GABAergic Interneurons in the Regulation of Striatal Output Pathways, J. Neurosci, vol.30, pp.2223-2234, 2010. ,
Recurrent Collateral Connections of Striatal Medium Spiny Neurons Are Disrupted in Models of Parkinson's Disease, J. Neurosci, vol.28, pp.5504-5512, 2008. ,
Current and experimental treatments of Parkinson disease: A guide for neuroscientists, J. Neurochem, pp.325-337, 2016. ,
, D1/D3 Receptors and Their Signaling Pathway. A Synopsis Park. Dis, pp.1-28, 2014.
Treatment of Nonmotor Symptoms in Parkinson's Disease. Parkinson's Disease, 2017. ,
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update, Lancet Neurol, vol.16, pp.238-250, 2017. ,
Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry, Prog. Neurobiol, vol.151, pp.57-100, 2017. ,
Apathy and impulse control disorders: Yin & yang of dopamine dependent behaviors, J. Parkinsons. Dis, vol.5, pp.625-636, 2015. ,
Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors, Synapse, vol.69, pp.183-189, 2015. ,
Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease? Front, Psychiatry, vol.7, pp.1-13, 2016. ,
Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study, Clin. Neuropharmacol, vol.37, pp.9-16, 2014. ,
Long-term safety and tolerability of ProSavin , a lentiviral vector-based gene therapy for Parkinson ' s disease : a dose escalation , open-label , phase 1 / 2 trial, vol.383, 2014. ,
Long-term follow up of a phase 1/2 study of ProSavin, a lentiviral vector gene therapy for Parkinson's disease. Hum, Gene Ther. Clin. Dev, vol.33, 2018. ,
Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: A new susceptibility locus on chromosome 1p22-p21?, Am. J. Med. Genet. Part B Neuropsychiatr. Genet, vol.153, pp.1200-1208, 2010. ,
Association study in three different populations between the GPR88 gene and major psychoses, Mol. Genet. genomic Med, vol.2, pp.152-161, 2014. ,
Deleterious mutation in GPR88 is associated with chorea, speech delay, and learning disabilities, Neurol. Genet, vol.2, pp.64-64, 2016. ,
A Novel G-Protein-Coupled Receptor Gene Expressed in Striatum, Online, vol.321, pp.314-321, 2000. ,
PANTHER version 11: Expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements, Nucleic Acids Res, vol.45, pp.183-189, 2017. ,
Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing, Brain Struct. Funct, 2017. ,
Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents, Eur. J. Neurosci, vol.30, pp.397-414, 2009. ,
Developmental and adult expression patterns of the G protein-coupled receptor GPR88 in the rat: establishment of a dual nuclear-cytoplasmic localization, J. Comp. Neurol. Res. Syst. Neurosci, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01594963
GPR88: A putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation, Basal Ganglia, vol.1, pp.83-89, 2011. ,
Lack of GPR88 enhances medium spiny neuron activity and alters motorand cue-dependent behaviors, Nat. Neurosci, vol.15, pp.1547-55, 2012. ,
A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types, Cell, vol.135, pp.738-748, 2008. ,
Distribution and Regulation of the G Protein-Coupled Receptor Gpr88 in the Striatum: Relevance to Parkinson's Disease, 2012. ,
Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex, Neuron, vol.45, pp.861-872, 2005. ,
Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: An expanded convergent functional genomics approach, Mol. Psychiatry, vol.9, pp.1007-1029, 2004. ,
Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine, Mol. Psychiatry, vol.12, pp.167-189, 2007. ,
Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats, Mol. Psychiatry, vol.20, pp.951-958, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02361884
Synthesis, Pharmacological Characterization, and Structure-Activity Relationship Studies of Small Molecular Agonists for the Orphan GPR88 Receptor, ACS Chem. Neurosci, vol.5, pp.576-587, 2014. ,
Mice lacking GPR88 show motor deficit, improved spatial learning and low anxiety reversed by delta opioid antagonist, Biol. Psychiatry, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01594891
Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: Clues for RGS2 and RGS4 functions, J. Neurochem, vol.84, pp.1118-1127, 2003. ,
The role of regulator of G protein signaling 4 in delta-opioid receptormediated behaviors, Psychopharmacology (Berl), vol.234, pp.29-39, 2017. ,
RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits, Neuron, vol.73, pp.347-359, 2012. ,
RGS4 overexpression in the rat dorsal striatum modulates mGluR5-and amphetamine-mediated behavior and signaling, Psychopharmacology (Berl), vol.221, pp.621-635, 2012. ,
The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?, Mol. Cell. Neurosci, vol.42, pp.438-447, 2009. ,
GPR88 in A2Areceptor-expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating, Eur. J. Neurol, pp.0-2, 2017. ,
DARPP-32: An Integrator of Neurotransmission, Annu. Rev. Pharmacol. Toxicol, vol.44, pp.269-296, 2004. ,
Remodeling of Sensorimotor Brain Connectivity in Gpr88 deficient mice, Brain Connect, vol.7, pp.526-540, 2017. ,
Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks, Biol. Psychiatry, 2018. ,
Striatal GPR88 Modulates Foraging Efficiency, J. Neurosci, vol.37, pp.7939-7947, 2017. ,
Lack of anticipatory behavior in Gpr88 knockout mice showed by automatized home cage phenotyping. Genes, Brain Behav, pp.0-2, 2018. ,
, D2R-neurons enhances anxiety-like behaviors, 2016.
GPR88 is a critical regulator of feeding and body composition in mice, Sci. Rep, vol.7, 2017. ,
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease, J. Neurosci, vol.36, pp.9161-9172, 2016. ,
Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry, Prog. Neurobiol, vol.151, pp.57-100, 2017. ,
The unilateral 6-hydroxydopamine lesion model in behavioral brain research, Prog. Neurobiol, vol.50, pp.275-331, 1996. ,
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?, Transl. Psychiatry, vol.6, p.753, 2016. ,
Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae, Prog. Neurobiol, vol.49, pp.215-266, 1996. ,
Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease, Mol Psychiatry, vol.19, pp.358-367, 2014. ,
The RNAi revolution, Nature, vol.430, pp.161-164, 2004. ,
Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors. Hum, Gene Ther, vol.17, pp.253-263, 2006. ,
Progress and problems with the use of viral vectors for gene therapy, Nat. Rev. Genet, vol.4, pp.346-358, 2003. ,
Striatal Overexpression of FosB Reproduces Chronic Levodopa-Induced Involuntary Movements, J. Neurosci, vol.30, pp.7335-7343, 2010. ,
Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment, Brain Res, vol.825, pp.104-114, 1999. ,
Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats, Brain Res, vol.771, pp.271-277, 1997. ,
D1-receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression, Mol. Brain Res, vol.53, pp.69-77, 1998. ,
Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity, Cell. Signal, vol.16, pp.711-721, 2004. ,
Regulators of G-protein signaling 4: Modulation of 5-HT1A-mediated neurotransmitter release in vivo, Brain Res, vol.1022, pp.214-220, 2004. ,
Activation of extracellular signal-regulated kinase (ERK) and Akt by human serotonin 5-HT(1B) receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4, J. Neurochem, vol.75, pp.934-938, 2000. ,
RGS4 modulates serotonin signaling in prefrontal cortex and links to serotonin dysfunction in a rat model of schizophrenia, Mol. Pharmacol, vol.71, pp.1030-1039, 2007. ,
Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington's Disease, Cell Rep, vol.22, pp.110-122, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02091323
Dysregulated Neurotransmission induces Trans-synaptic degeneration in reconstructed, Neuronal Networks. Sci. Rep, vol.8, pp.1-12, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01907549
The Attentional Set Shifting Task: A Measure of Cognitive Flexibility in Mice, J. Vis. Exp, vol.2, issue.7, 2015. ,
Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease, PLoS One, vol.12, pp.1-19, 2017. ,
Neurocognitive Signs in Prodromal Huntington Disease, Neuropsychology, vol.25, pp.1-14, 2011. ,
Addiction: failure of control over maladaptive incentive habits, Curr. Opin. Neurobiol, pp.564-572, 2013. ,
Striatal circuits, habits, and implications for obsessive-compulsive disorder, Curr. Opin. Neurobiol, vol.30, pp.59-65, 2015. ,
, but Dissociable, Processing in Discrete Corticostriatal Inputs Encodes Skill Learning, vol.96, p.5, 2017.
Recent insights into corticostriatal circuit mechanisms underlying habits, Curr. Opin. Behav. Sci, vol.20, pp.40-46, 2018. ,
Methamphetamine promotes habitual action and alters the density of striatal glutamate receptor and vesicular proteins in dorsal striatum, Addict. Biol, vol.23, pp.857-867, 2018. ,
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation, Neuron, vol.90, pp.1312-1324, 2016. ,
Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits, Cell, vol.162, pp.635-647, 2015. ,
Spiraling dopaminergic circuitry from the ventral striatum to dorsal striatum is an effective feed-forward loop, Neuroscience, vol.241, pp.126-134, 2013. ,
Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors, Science, vol.340, pp.1243-1246, 2013. ,
, Goal-Directed Decision Making, 2018.
Pulling habits out of rats: adenosine 2A receptor antagonism in dorsomedial striatum rescues meth-amphetamineinduced deficits in goal-directed action, Addict. Biol, vol.22, pp.172-183, 2015. ,